Pig kidney transplants begin: a lifeline for kidney patients?
NCT ID NCT06878560
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 27 times
Summary
This study tests a genetically modified pig kidney (called the 10 GE Xenokidney) in 50 adults with end-stage kidney disease who cannot get a human kidney transplant or are unlikely to receive one in time. Participants will receive the pig kidney and be followed for at least 24 weeks to see how well it works and if it is safe, with lifelong monitoring for infections. The goal is to provide a new treatment option for people who have few alternatives.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
New York University Langone Health
RECRUITINGNew York, New York, 10016, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Northwestern Memorial Hospital
RECRUITINGChicago, Illinois, 60611, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.